The recent close of $4.67 is approximately 19% below the fair value buy target for the stock and approximately 60% below the fair value close target for the stock. The recent close is also 7% below analysts' $5.00 median target for the stock.
The stock currently has a trailing twelve month PE Ratio of 9, a PEG Ratio of 0.04, and a Price to Tangible Book Ratio of (9.5).
In the past 52 weeks, share prices have moved between a high of $5.50 and a low of $2.96. With the recent close, the stock is trading 18% below the 52 week high and 37% above the 52 week low.
Affymetrix, Inc. develops, manufacturers, and sells, genetic analysis products for the life sciences research and clinical healthcare industries.
All valuations are based on the listed company's most recent SEC annual filing, and all prices are per share.
Wax Ink is a baseline equity research company comprised of individual investors, NOT licensed or registered with ANY government agency.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.